STOCK TITAN

Merus to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Merus N.V. announced that its CEO, Bill Lundberg, will participate in two investor conferences: BMO Biopharma Spotlight Series: Oncology Day on November 8 and Stifel 2023 Healthcare Conference on November 14. The BMO conference will have a fireside chat with no live webcast, while the Stifel conference will have a live webcast. Archived presentations will be available on the company's website for a limited time.
Positive
  • None.
Negative
  • None.

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in the following investor conferences:

  • BMO Biopharma Spotlight Series: Oncology Day (fireside chat): Wednesday, November 8 at 11:30-11:55 a.m. ET (No live webcast, replay will be available after the event)
  • Stifel 2023 Healthcare Conference (fireside chat): Tuesday, November 14 at 1:15-1:45 p.m. ET (Live webcast available contemporaneously)

Archived presentations will also be available on the Investors page of the Company's website for a limited time after the event.

About Merus
Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For additional information, please visit Merus’ website and twitter.

Multiclonics®, Biclonics® and Triclonics® are registered trademarks of Merus N.V.



FAQ

When will Bill Lundberg participate in the BMO Biopharma Spotlight Series: Oncology Day?

Bill Lundberg will participate in the BMO Biopharma Spotlight Series: Oncology Day on Wednesday, November 8.

When will Bill Lundberg participate in the Stifel 2023 Healthcare Conference?

Bill Lundberg will participate in the Stifel 2023 Healthcare Conference on Tuesday, November 14.

Will there be a live webcast for the BMO Biopharma Spotlight Series: Oncology Day?

No, there will be no live webcast for the BMO Biopharma Spotlight Series: Oncology Day. However, a replay will be available after the event.

Will there be a live webcast for the Stifel 2023 Healthcare Conference?

Yes, there will be a live webcast available for the Stifel 2023 Healthcare Conference.

Where can I find archived presentations of the conferences?

Archived presentations will be available on the Investors page of Merus N.V.'s website for a limited time after the event.

Merus N.V. Common Shares

NASDAQ:MRUS

MRUS Rankings

MRUS Latest News

MRUS Stock Data

2.89B
66.39M
2.03%
105.65%
12.79%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
3584 CM UTRECHT